untitled (25)

Weekly market opportunities in T-Advisor: the best on February 20th

Market Opportunities

, No hay comentarios

T-Advisor updates weekly a list of market opportunities from several stocks exchanges around the world. We sum up a selection of the best ones:


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. They focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and are also selectively active in the areas of autoimmunity, neuroscience, and infection. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide. investment opportunity europe astra zeneca graph investment opportunity europe astra zeneca


Ilumina Inc (NASDAQ): Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina’s based solutions focus on DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. Their customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. investment opportunity america illiminia inc graph investment opportunity america illiminia inc


Leighton Holdings (AUSTRALIA STOCK EXCHANGE): World-leading infrastructure, mining, services, and public-private partnerships group. With a history since 1899, and more than 50,000 people in 20 countries is a member of the S&P/ASX 100 index, the Dow Jones Sustainability Australia Index and FTSE4Good. Also has a 45% investment in HLG Contracting, a 59.11% investment in Devine and a 47% investment in Ventia. investment opportunity asia-pacific leighton holdings graph investment opportunity asia-pacific leighton holdings

Find more opportunities from the main exchanges in the world on our module “Market opportunities” in T-Advisor.

Se el primero en escribir un comentario.

Escribir un comentario: